June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Tbx5 is a novel transcriptional regulator of the EphA5 promoter
Author Affiliations & Notes
  • Deborah C Otteson
    Optometry, University of Houston, Houston, Texas, United States
  • Steve Huynh
    Optometry, University of Houston, Houston, Texas, United States
  • JianBo Wang
    Optometry, University of Houston, Houston, Texas, United States
  • Footnotes
    Commercial Relationships   Deborah Otteson, None; Steve Huynh, None; JianBo Wang, None
  • Footnotes
    Support  NIH grants EY021792, EY007551
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 589. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Deborah C Otteson, Steve Huynh, JianBo Wang; Tbx5 is a novel transcriptional regulator of the EphA5 promoter. Invest. Ophthalmol. Vis. Sci. 2017;58(8):589.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Forward and reverse signaling through ephrin ligands and their receptors (EPH) regulates formation of topographical maps in the visual system. EphA5 is expressed in a temporal high/nasal low gradient across the developing and mature retina. To identify novel regulators of the EphA5 promoter, whole transcriptome sequencing was used to analyze differential gene expression in the temporal and nasal retinal ganglion cell layer (GCL).

Methods : Temporal and nasal thirds of the GCL from postnatal day 2 (P2) C57Bl/6J mice were isolated using laser capture microdissection for RNA sequencing (Illumina). RT-qPCR of independent RNA samples isolated from temporal (n=3) and nasal (n=3) retinal thirds used hydrolysis probes (TaqMan) and Relative Expression Software Tool analysis. Tbx5 (T-box5) subcloned into pcDNA3.1 or empty pcDNA3.1 plasmids were co-transfected with mEphA5-pGL2 luciferase promoter constructs into 293FT cells. Relative luciferase, normalized to co-transfected pCMV-βgal, was compared by ANOVA and post-hoc T-tests. Developmental expression of TBX5 in mouse retinas used immuno-fluorescence labeling and confocal microscopy. Chromatin immunoprecipitation (ChIP) used sheared chromatin from P7 retinas and antibodies against TBX5 or IgG followed by qPCR analysis .

Results : At P2, 40 genes showed a 2-fold or greater difference in expression between temporal and nasal GCL by RNA-seq, with Tbx5 increased 5.3-fold in the temporal GCL (p=0.017 vs. nasal). By RT-qPCR, Tbx5 expression was 15.6-fold higher in temporal vs. nasal retinal RNA at P2 (p=0.001). The mouse EphA5 proximal promoter region contained four putative TBX binding sites (T-box), located between -1080 and -146. Overexpression of Tbx5 increased activity of EphA5 promoter constructs (ANOVA, p<0.001), with effect sizes ranging from 7.4-fold (p=0.04; 1 TBX site), to 18.3-fold (p=0.02; 4 TBX sites). TBX5 occupancy of the proximal EphA5 promoter in vivo was confirmed by ChIP, with a 330-fold enrichment (TBX5 vs. IgG) by qPCR. A distal T-box site, located at -2910 from the EphA5 transcription start site, was not amplified from TBX5 ChIP’ed chromatin. By immunofluorescence, TBX5 was detected in retinal ganglion cells at embryonic day14.5.

Conclusions : During early retinal development, Tbx5 is known to play a role in dorsal/ventral patterning. Our data point to a novel role for Tbx5 in regulating nasal/temporal gene expression of EphA5 in later stages of retinal development.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.